+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

P

Actively Recruiting

Healthy Volunteer

Researchers are evaluating a non-ablative 1470 nm laser to treat androgenetic alopecia and scarring alopecia in this single-center, open-label pilot study. The study aims to assess the safety and effects of this laser treatment, which is FDA-cleared for dermatologic use but not yet tested for these types of hair loss. Up to 10 participants with biopsy-proven alopecia will take part, divided into two groups based on their condition. Participants will receive up to three treatments with the Sciton HALO 1470nm laser, which creates controlled micro-channels in the scalp skin to improve healing and delivery of topical treatments. Each treatment targets specific areas of hair loss and lasts about 10 to 15 minutes. Pretreatment involves topical anesthetic and antiseptic cleaning, and post-treatment care includes applying a corticosteroid cream. Two treatment groups will be monitored separately for androgenetic and scarring alopecia. Throughout the study, participants will attend follow-up visits at months 6, 9, 12, and 15. At each visit, standardized photographs and hair density measurements will be taken and compared to baseline to monitor progress. Additional evaluations include pain scores, patient questionnaires, and blinded assessments of hair growth. Participants are encouraged to report any side effects during the study, which lasts up to 15 months from the first treatment.

Age: 18Years - 99YearsAll GendersPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the effectiveness and safety of a hybrid fractional laser treatment called the Sciton Halo for acne scars, focusing particularly on patients with darker skin tones Fitzpatrick IV and V. Acne scarring can significantly impact quality of life and mental health, yet treating certain types of scars remains challenging. This study aims to assess how well this combined ablative and non-ablative laser improves scar appearance and tolerability in people with different skin types. Participants will be divided into two groups based on skin type Fitzpatrick IV-V and Fitzpatrick I-III. Each group will receive up to three laser treatment sessions using the Sciton Halo. Before starting treatment, participants may use prescribed skin care products like hydroquinone or retinol to reduce risks of hyperpigmentation. At each treatment visit, photographs will be taken and participants will complete quality of life and satisfaction surveys to monitor progress and experiences. Throughout the study, participants will have follow-up assessments up to nine months after baseline. Researchers will measure changes in acne scar severity, clinician evaluations of improvement, patient satisfaction, skin texture, pigmentation, and adherence to skin care recommendations. Safety aspects such as side effects and pain levels will also be tracked. This trial is sponsored by Montefiore Medical Center and involves ongoing observation to evaluate both treatment results and tolerability over time.

Age: 18Years +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the use of a non-ablative 1470 nm laser to treat scarring alopecia in adults. This study aims to determine if the laser effectively treats scarring alopecia and to understand the molecular pathways affected by the laser in hair follicles. The trial includes participants with biopsy-proven or clinically diagnosed scarring alopecia who have not had recent hair loss treatments. Participants will receive three laser treatments spaced one month apart using the non-ablative Sciton HALO laser. Each session lasts about 10 to 15 minutes and involves applying a topical anesthetic and cleaning the scalp before treatment. The laser creates controlled micro-channels in the skin to minimize tissue damage while potentially improving treatment effects. After treatment, participants will follow standard care guidelines. During the study, hair follicle samples will be collected by plucking hairs before the first treatment and one month after the last treatment to analyze gene expression related to inflammation and fibrosis. Participants will attend five follow-up visits over 15 months for clinical assessments, including hair density measurement with a specialized device and photographic evaluations. They will also complete questionnaires, self-assessments, and keep a diary of any side effects. The main outcomes measured include hair density, hair counts, and aesthetic improvement scales over time.

Age: 18Years +All GendersPhase Not Applicable
1 location